孤儿药物-话题@MedSci

#孤儿药物#

41篇内容 | 924人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1740118, encodeId=fcdf1e401181e, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=MIV-818治疗原发性肝细胞癌：已获FDA孤儿药物称号, objectType=article, longId=193722, objectId=694a193e22bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=694a193e22bb, replyNumber=0, likeNumber=40, createdTime=2020-05-24, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=694a193e22bb, moduleTitle=MIV-818治疗原发性肝细胞癌：已获FDA孤儿药物称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=694a193e22bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740119, encodeId=ed391e40119af, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=关注罕见病“真性红细胞增多症”：PTG-300获美国FDA孤儿药物认定, objectType=article, longId=196104, objectId=ff9919610447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff9919610447, replyNumber=0, likeNumber=38, createdTime=2020-09-11, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff9919610447, moduleTitle=关注罕见病“真性红细胞增多症”：PTG-300获美国FDA孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff9919610447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740120, encodeId=3d481e4012095, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=miR-155抑制剂治疗T细胞淋巴瘤，获得美国FDA的孤儿药物指定, objectType=article, longId=197998, objectId=2dca19e99888, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dca19e99888, replyNumber=0, likeNumber=35, createdTime=2020-09-24, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dca19e99888, moduleTitle=miR-155抑制剂治疗T细胞淋巴瘤，获得美国FDA的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dca19e99888)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740113, encodeId=b06c1e40113fe, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Glenmark双特异性抗体GBR 1342治疗多发性骨髓瘤，喜获FDA孤儿药物指定, objectType=article, longId=179623, objectId=75b91e96234a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75b91e96234a, replyNumber=0, likeNumber=48, createdTime=2020-04-27, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75b91e96234a, moduleTitle=Glenmark双特异性抗体GBR 1342治疗多发性骨髓瘤，喜获FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75b91e96234a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740109, encodeId=84911e4010947, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=脑转移性乳腺癌的治疗进展：FDA授予NERLYNX孤儿药物指定, objectType=article, longId=178843, objectId=ea0e1e88433a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea0e1e88433a, replyNumber=0, likeNumber=42, createdTime=2019-11-29, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea0e1e88433a, moduleTitle=脑转移性乳腺癌的治疗进展：FDA授予NERLYNX孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea0e1e88433a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740106, encodeId=1f671e40106d0, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Neuropore宣布其NPT520-34治疗肌萎缩性脊髓侧索硬化症，喜获FDA的孤儿药物指定, objectType=article, longId=177715, objectId=7abe1e771504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7abe1e771504, replyNumber=0, likeNumber=37, createdTime=2019-08-20, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7abe1e771504, moduleTitle=Neuropore宣布其NPT520-34治疗肌萎缩性脊髓侧索硬化症，喜获FDA的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7abe1e771504)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740110, encodeId=ae521e4011078, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=骨髓增生异常综合征的治疗：ASTX727已获美国FDA的孤儿药物指定, objectType=article, longId=178844, objectId=61061e884412, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61061e884412, replyNumber=0, likeNumber=29, createdTime=2020-05-03, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61061e884412, moduleTitle=骨髓增生异常综合征的治疗：ASTX727已获美国FDA的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61061e884412)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740112, encodeId=3b8d1e4011270, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=美国FDA授予Nomacopan治疗大疱性类天疱疮的孤儿药物指定, objectType=article, longId=179480, objectId=a6c61e94804e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6c61e94804e, replyNumber=0, likeNumber=42, createdTime=2019-09-30, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6c61e94804e, moduleTitle=美国FDA授予Nomacopan治疗大疱性类天疱疮的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6c61e94804e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740108, encodeId=966d1e4010889, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=CARsgen Therapeutics公司的多发性骨髓瘤CAR-T细胞疗法喜获FDA的孤儿药物指定, objectType=article, longId=178782, objectId=c6a71e8782a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6a71e8782a5, replyNumber=0, likeNumber=39, createdTime=2019-11-18, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6a71e8782a5, moduleTitle=CARsgen Therapeutics公司的多发性骨髓瘤CAR-T细胞疗法喜获FDA的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6a71e8782a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740102, encodeId=11b71e4010246, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Aridis柠檬酸镓吸入剂AR-501治疗囊性纤维化肺部感染，喜获EMA孤儿药物指定, objectType=article, longId=175954, objectId=2cb91e5954e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cb91e5954e9, replyNumber=0, likeNumber=40, createdTime=2019-08-10, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cb91e5954e9, moduleTitle=Aridis柠檬酸镓吸入剂AR-501治疗囊性纤维化肺部感染，喜获EMA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cb91e5954e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740114, encodeId=b3951e40114a0, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=欧盟委员会授予分泌酶抑制剂Nirogacestat治疗软组织肉瘤的孤儿药物称号, objectType=article, longId=180051, objectId=4784180051be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4784180051be, replyNumber=0, likeNumber=47, createdTime=2020-05-21, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4784180051be, moduleTitle=欧盟委员会授予分泌酶抑制剂Nirogacestat治疗软组织肉瘤的孤儿药物称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4784180051be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740116, encodeId=41a51e40116e4, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=3D生物打印取得里程碑式进展：FDA授予AuriNovo孤儿药物认定用于小耳畸形患者的耳部重建, objectType=article, longId=183363, objectId=3740183363d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3740183363d9, replyNumber=0, likeNumber=32, createdTime=2020-10-27, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3740183363d9, moduleTitle=3D生物打印取得里程碑式进展：FDA授予AuriNovo孤儿药物认定用于小耳畸形患者的耳部重建, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3740183363d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740101, encodeId=775b1e4010139, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=阿斯利康的PD-L1单抗Imfinzi治疗小细胞肺癌，获得FDA的孤儿药物指定, objectType=article, longId=175359, objectId=a0671e535994, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0671e535994, replyNumber=0, likeNumber=31, createdTime=2020-06-18, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0671e535994, moduleTitle=阿斯利康的PD-L1单抗Imfinzi治疗小细胞肺癌，获得FDA的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0671e535994)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740104, encodeId=34541e4010431, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定, objectType=article, longId=176182, objectId=3d741e61824e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d741e61824e, replyNumber=0, likeNumber=39, createdTime=2019-11-07, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d741e61824e, moduleTitle=急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d741e61824e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740103, encodeId=61ab1e40103c7, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Menin-MLL抑制剂KO-539获FDA的孤儿药物认定用于治疗急性髓细胞白血病, objectType=article, longId=176178, objectId=4e8f1e617823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e8f1e617823, replyNumber=0, likeNumber=34, createdTime=2019-10-22, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e8f1e617823, moduleTitle=Menin-MLL抑制剂KO-539获FDA的孤儿药物认定用于治疗急性髓细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e8f1e617823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740117, encodeId=a3361e4011723, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=抗体药物偶联物OBI-999治疗胰腺癌获得FDA孤儿药物认定, objectType=article, longId=185335, objectId=6cc718533567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cc718533567, replyNumber=0, likeNumber=29, createdTime=2020-06-25, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cc718533567, moduleTitle=抗体药物偶联物OBI-999治疗胰腺癌获得FDA孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cc718533567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740098, encodeId=39d61e400988b, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Autolus双靶头CAR-T疗法AUTO3治疗急性淋巴细胞白血病，获得FDA授予的孤儿药物指定, objectType=article, longId=164953, objectId=996316495364, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=996316495364, replyNumber=0, likeNumber=37, createdTime=2019-12-22, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=996316495364, moduleTitle=Autolus双靶头CAR-T疗法AUTO3治疗急性淋巴细胞白血病，获得FDA授予的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=996316495364)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740107, encodeId=45fd1e401071b, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=嗜酸性粒细胞性食管炎：Fasenra被FDA授予孤儿药物资格, objectType=article, longId=178352, objectId=af411e83525b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af411e83525b, replyNumber=0, likeNumber=46, createdTime=2020-04-13, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af411e83525b, moduleTitle=嗜酸性粒细胞性食管炎：Fasenra被FDA授予孤儿药物资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af411e83525b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740099, encodeId=a2591e4009908, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=急性髓细胞白血病的治疗：FDA授予BST-236孤儿药物认定, objectType=article, longId=167756, objectId=3be616e75661, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be616e75661, replyNumber=0, likeNumber=34, createdTime=2019-06-14, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be616e75661, moduleTitle=急性髓细胞白血病的治疗：FDA授予BST-236孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3be616e75661)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740095, encodeId=4a321e4009522, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Espero BioPharma宣布Tecarfarin治疗终末期肾病和心房颤动患者获得FDA孤儿药物指定, objectType=article, longId=162178, objectId=41161621e864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41161621e864, replyNumber=0, likeNumber=47, createdTime=2019-07-11, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41161621e864, moduleTitle=Espero BioPharma宣布Tecarfarin治疗终末期肾病和心房颤动患者获得FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41161621e864)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

孤儿药物

2020-05-29

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

MIV-818治疗原发性肝细胞癌：已获FDA孤儿药物称号

2020-05-24

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

关注罕见病“真性红细胞增多症”：PTG-300获美国FDA孤儿药物认定

2020-09-11

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

miR-155抑制剂治疗T细胞淋巴瘤，获得美国FDA的孤儿药物指定

2020-09-24

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Glenmark双特异性抗体GBR 1342治疗多发性骨髓瘤，喜获FDA孤儿药物指定

2020-04-27

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

脑转移性乳腺癌的治疗进展：FDA授予NERLYNX孤儿药物指定

2019-11-29

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Neuropore宣布其NPT520-34治疗肌萎缩性脊髓侧索硬化症，喜获FDA的孤儿药物指定

2019-08-20

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

骨髓增生异常综合征的治疗：ASTX727已获美国FDA的孤儿药物指定

2020-05-03

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

美国FDA授予Nomacopan治疗大疱性类天疱疮的孤儿药物指定

2019-09-30

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

CARsgen Therapeutics公司的多发性骨髓瘤CAR-T细胞疗法喜获FDA的孤儿药物指定

2019-11-18

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Aridis柠檬酸镓吸入剂AR-501治疗囊性纤维化肺部感染，喜获EMA孤儿药物指定

2019-08-10

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

欧盟委员会授予分泌酶抑制剂Nirogacestat治疗软组织肉瘤的孤儿药物称号

2020-05-21

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

3D生物打印取得里程碑式进展：FDA授予AuriNovo孤儿药物认定用于小耳畸形患者的耳部重建

2020-10-27

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

阿斯利康的PD-L1单抗Imfinzi治疗小细胞肺癌，获得FDA的孤儿药物指定

2020-06-18

智慧医人 (审核中...)

前往app查看评论内容

#孤儿药物#

急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定

2019-11-07

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Menin-MLL抑制剂KO-539获FDA的孤儿药物认定用于治疗急性髓细胞白血病

2019-10-22

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

抗体药物偶联物OBI-999治疗胰腺癌获得FDA孤儿药物认定

2020-06-25

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Autolus双靶头CAR-T疗法AUTO3治疗急性淋巴细胞白血病，获得FDA授予的孤儿药物指定

2019-12-22

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

嗜酸性粒细胞性食管炎：Fasenra被FDA授予孤儿药物资格

2020-04-13

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

急性髓细胞白血病的治疗：FDA授予BST-236孤儿药物认定

2019-06-14

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Espero BioPharma宣布Tecarfarin治疗终末期肾病和心房颤动患者获得FDA孤儿药物指定

2019-07-11

科室
- - 订阅+
  - 更多科室
工具
服务